Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a common spice help kidney transplant patients?

NCT ID NCT03935958

Disease control Sponsor: University of Illinois at Chicago Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 2 times

Summary

This small pilot study is testing whether curcumin, the active ingredient in turmeric, can improve blood vessel health and thinking skills in kidney transplant recipients. Fourteen participants will take either curcumin or a placebo for 12 months. The goal is to see if this safe, natural supplement offers any benefit for a group with few treatment options.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
curcumin (a dietary supplement)
What this could lead to
If it works, this could point toward a simple supplement to help protect blood vessels and thinking skills in kidney transplant patients.
What could go wrong
This is a very small pilot study with only 14 people, so results may not apply to everyone. Curcumin is a supplement, not a proven treatment, and may not show clear benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

14 people

The number who actually took part.

Started

Nov 2019

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. The subject is a recipient of a living donor or deceased donor kidney only transplant 2. The subject is \> 18 years of age Exclusion Criteria: 1. The subject has had a multi-organ transplant 2. Subjects that were taking curcumin pre-transplant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Disorder related to renal transplantation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction disease related to solid organ transplantation disease related to transplantation Inflammation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Disorder related to renal transplantation

Contacts and locations

Locations

  • University of Illinois at Chicago

    Chicago, Illinois, 60612, United States